아기오스제약(주)
MX ˙ BMV ˙ US00847X1046
SecurityMX:AGIO / Agios Pharmaceuticals, Inc.
InstitutionMarshall Wace, Llp
Latest Disclosed Ownership448,118 shares
Latest Disclosed Value $ 15,159,832
Marshall Wace, Llp reports 26.72% increase in ownership of AGIO / Agios Pharmaceuticals, Inc.

On May 14, 2026 - Marshall Wace, Llp filed a 13F-HR form disclosing ownership of 448,118 shares of Agios Pharmaceuticals, Inc. (MX:AGIO) valued at $15,159,832 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 353,639 shares of Agios Pharmaceuticals, Inc.. This represents a change in shares of 26.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 448,118 94,479 26.72 15,160 57.48 0.0151
2026-02-13 2025-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 353,639 126,815 55.91 9,626 5.73 0.0088
2025-11-13 2025-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 226,824 -457,845 -66.87 9,105 -60.02 0.0092
2025-08-13 2025-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 684,669 163,796 31.45 22,772 49.22 0.0257
2025-05-15 2025-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 520,873 -110,755 -17.53 15,262 -26.47 0.0194
2025-02-13 2024-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 631,628 -631,657 -50.00 20,755 -63.02 0.0250
2024-11-14 2024-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 1,263,285 129,550 11.43 56,128 14.81 0.0684
2024-08-14 2024-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 1,133,735 855,739 307.82 48,887 501.45 0.0653
2024-05-15 2024-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 277,996 277,996 8,129 0.0124
2024-02-14 2023-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -58,040 -100.00 0 -100.00
2023-11-14 2023-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 58,040 58,040 1,436 0.0029
2023-02-14 2022-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -14,413 -100.00 0 -100.00
2022-11-14 2022-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 14,413 -29,150 -66.91 408 -57.76 0.0009
2022-08-15 2022-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 43,563 43,563 966 0.0020
2022-05-16 2022-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -14,581 -100.00 0 -100.00
2022-02-14 2021-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 14,581 14,581 479 0.0009
2021-05-17 2021-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -43,878 -100.00 0 -100.00
2021-02-16 2020-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 43,878 4,285 10.82 1,901 37.16 0.0103
2020-11-16 2020-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 39,593 39,593 1,386 0.0089
2020-08-13 2020-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -55,234 -100.00 0 -100.00
2020-05-15 2020-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 55,234 -119,501 -68.39 1,959 -76.52 0.0196
2020-02-14 2019-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 174,735 103,475 145.21 8,344 261.37 0.0573
2019-11-14 2019-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 71,260 71,260 2,309 0.0182
2019-05-14 2019-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -3,717 -100.00 0 -100.00
2019-02-14 2018-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 3,717 3,717 171 0.0017
2018-11-14 2018-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -5,490 -100.00 0 -100.00
2018-08-14 2018-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 5,490 2,716 97.91 462 103.52 0.0069
2018-05-15 2018-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 2,774 2,774 227 0.0094
2018-03-29 2017-12-31 13F/A-1 AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -9,587 -100.00 0 -100.00
2017-11-13 2017-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 9,587 9,587 642 0.0298
2017-05-12 2017-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -30,528 -100.00 0 -100.00
2017-02-10 2016-12-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 30,528 -76,895 -71.58 1,274 -77.55 0.0084
2016-11-10 2016-09-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 107,423 107,423 5,675 0.0403
2016-08-12 2016-06-30 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 0 -9,474 -100.00 0 -100.00
2016-05-13 2016-03-31 13F AGIOS PHARMACEUT COMMON STOCK 00847X104 9,474 9,474 385 0.0037
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.